We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Head and Neck Cancer Patients Can Benefit from Increased Radiation Therapy

By MedImaging International staff writers
Posted on 14 Feb 2017
Print article
Image: The researchers have found that hyperfractionated radiotherapy, and increased radiation therapy could save the lives of more head and neck cancer patients (Photo courtesy of Drugs Information Online).
Image: The researchers have found that hyperfractionated radiotherapy, and increased radiation therapy could save the lives of more head and neck cancer patients (Photo courtesy of Drugs Information Online).
Researchers have shown that treating head and neck cancer patients twice daily with radiation therapy, combined with chemotherapy, could benefit these patients and save more lives.

The study included patients with mouth, throat, or voice box tumors that already spread to adjacent tissue. The twice-daily treatment, called hyperfractionated radiotherapy, enables patients to receive a higher dose, and more effective radiotherapy treatment, possibly without increasing side effects.

The study was led by researchers at the Gustave Roussy Cancer Center and carried out together with the European CanCer Organization. The results were presented at the European Cancer Congress 2017 meeting.

The researchers used data from 117 different trials, and 28,804 patients worldwide for their study, and were able to compare 16 different treatments. The results showed that hyperfractionated radiotherapy together with chemotherapy, reduced cancer deaths by 20% compared with standard once-daily radiotherapy and chemotherapy. The treatment also reduced the risk of the cancer deteriorating by 23%.

Study leader, Dr Claire Petit, Gustave Roussy Cancer Center, said, "There are a number of new treatments that have shown promise in head and neck cancer trials. This large study has enabled us to compare several of these treatments to see which is best overall in terms of reducing mortality. Some of the studies we looked at did not include data on side effects; others did not follow patients long enough to pick up long-term side effects. This will be the focus of more research over the next year. Moreover, the method we used, network meta-analysis, which combines direct and indirect treatment comparisons, is a new method that needs to be interpreted with prudence. However, this is an important finding for this group of patients who have a higher risk of their cancer recurring following treatment."

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Digital Radiography Acquisition Software
VXvue with PureImpact
New
Thyroid Shield
Standard Thyroid Shield
New
Digital Radiography Generator
meX+20BT lite

Print article

Channels

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.